Literature DB >> 33031993

Acyl-CoA synthetases as regulators of brain phospholipid acyl-chain diversity.

Regina F Fernandez1, Jessica M Ellis2.   

Abstract

Each individual cell-type is defined by its distinct morphology, phenotype, molecular and lipidomic profile. The importance of maintaining cell-specific lipidomic profiles is exemplified by the numerous diseases, disorders, and dysfunctional outcomes that occur as a direct result of altered lipidome. Therefore, the mechanisms regulating cellular lipidome diversity play a role in maintaining essential biological functions. The brain is an organ particularly rich in phospholipids, the main constituents of cellular membranes. The phospholipid acyl-chain profile of membranes in the brain is rather diverse due in part to the high degree of cellular heterogeneity. These membranes and the acyl-chain composition of their phospholipids are highly regulated, but the mechanisms that confer this tight regulation are incompletely understood. A family of enzymes called acyl-CoA synthetases (ACSs) stands at a pinnacle step allowing influence over cellular acyl-chain selection and subsequent metabolic flux. ACSs perform the initial reaction for cellular fatty acid metabolism by ligating a Coenzyme A to a fatty acid which both traps a fatty acid within a cell and activates it for metabolism. The ACS family of enzymes is large and diverse consisting of 25-26 family members that are nonredundant, each with unique distribution across and within cell types, and differential fatty acid substrate preferences. Thus, ACSs confer a critical intracellular fatty acid selecting step in a cell-type dependent manner providing acyl-CoA moieties that serve as essential precursors for phospholipid synthesis and remodeling, and therefore serve as a key regulator of cellular membrane acyl-chain compositional diversity. Here we will discuss how the contribution of individual ACSs towards brain lipid metabolism has only just begun to be elucidated and discuss the possibilities for how ACSs may differentially regulate brain lipidomic diversity.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acyl-CoA synthetase; Brain; Fatty acid metabolic control; Polyunsaturated fatty acids

Mesh:

Substances:

Year:  2020        PMID: 33031993      PMCID: PMC8693597          DOI: 10.1016/j.plefa.2020.102175

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  188 in total

1.  Revisiting hydrophobic mismatch with free energy simulation studies of transmembrane helix tilt and rotation.

Authors:  Taehoon Kim; Wonpil Im
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

2.  Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.

Authors:  Cynthia G Van Horn; Jorge M Caviglia; Lei O Li; Shuli Wang; Deborah A Granger; Rosalind A Coleman
Journal:  Biochemistry       Date:  2005-02-08       Impact factor: 3.162

3.  The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase.

Authors:  Jordon M Inloes; Ku-Lung Hsu; Melissa M Dix; Andreu Viader; Kim Masuda; Thais Takei; Malcolm R Wood; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

4.  Determining the Bioenergetic Capacity for Fatty Acid Oxidation in the Mammalian Nervous System.

Authors:  Cory J White; Jieun Lee; Joseph Choi; Tiffany Chu; Susanna Scafidi; Michael J Wolfgang
Journal:  Mol Cell Biol       Date:  2020-04-28       Impact factor: 4.272

Review 5.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

6.  Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.

Authors:  Trisha J Grevengoed; Daniel E Cooper; Pamela A Young; Jessica M Ellis; Rosalind A Coleman
Journal:  FASEB J       Date:  2015-07-28       Impact factor: 5.191

Review 7.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 8.  Remodeling myelination: implications for mechanisms of neural plasticity.

Authors:  Kae-Jiun Chang; Stephanie A Redmond; Jonah R Chan
Journal:  Nat Neurosci       Date:  2016-02       Impact factor: 24.884

9.  FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.

Authors:  Ilaria Meloni; Maddalena Muscettola; Martine Raynaud; Ilaria Longo; Mirella Bruttini; Marie-Pierre Moizard; Marie Gomot; Jamel Chelly; Vincent des Portes; Jean-Pierre Fryns; Hans-Hilger Ropers; Barbara Magi; Cristina Bellan; Nila Volpi; Helger G Yntema; Sarah E Lewis; Jean E Schaffer; Alessandra Renieri
Journal:  Nat Genet       Date:  2002-03-11       Impact factor: 38.330

10.  Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain.

Authors:  Chuck T Chen; Alex P Kitson; Kathryn E Hopperton; Anthony F Domenichiello; Marc-Olivier Trépanier; Lauren E Lin; Leonardo Ermini; Martin Post; Frank Thies; Richard P Bazinet
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

View more
  2 in total

1.  Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.

Authors:  Christopher E Ramsden; Gregory S Keyes; Elizabeth Calzada; Mark S Horowitz; Daisy Zamora; Jahandar Jahanipour; Andrea Sedlock; Fred E Indig; Ruin Moaddel; Dimitrios Kapogiannis; Dragan Maric
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging.

Authors:  Regina F Fernandez; Andrea S Pereyra; Victoria Diaz; Emily S Wilson; Karen A Litwa; Jonatan Martínez-Gardeazabal; Shelley N Jackson; J Thomas Brenna; Brian P Hermann; Jeffrey B Eells; Jessica M Ellis
Journal:  JCI Insight       Date:  2021-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.